title: [Clinical usefulness of CA M26 and CA M29 in breast carcinoma].
authors.affiliation: U.O. Laboratorio di Analisi, Istituto Scientifico Oncologico, Bari, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Quaranta
authors.forename: G
authors.initials: G
authors.lastname: Micelli
authors.forename: M
authors.initials: M
authors.lastname: Coviello
authors.forename: A
authors.initials: A
authors.lastname: Donadeo
authors.forename: A
authors.initials: A
authors.lastname: Lozupone
authors.forename: F
authors.initials: F
authors.lastname: Schittulli
mesh_terms: D000951:Antigens, Neoplasm / Q000097:blood*; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000097:blood*; D005260:Female; D006801:Humans; D008875:Middle Aged
chemical_list: D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; C057387:mucinous carcinoma-associated antigen
vernacular_title: Utilità clinica del CA M26 e CA M29 nel carcinoma della mammella.